PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Latest evidence on using hormone replacement therapy for treating menopausal symptoms

2014-12-19
(Press-News.org) Hormone replacement therapy (HRT) is the most effective treatment for menopausal symptoms, in particular for younger women at the onset of the menopause, suggests a new review published today (19 December) in The Obstetrician & Gynaecologist (TOG).

The review highlights that menopausal symptoms, including hot flushes and night sweats are common, affecting around 70% of women for an average of 5 years but may continue for many years in about 10% of women.

Every woman experiences the menopause differently; some experience one or two symptoms mildly while others have more severe symptoms. Menopausal symptoms can be debilitating and can adversely affect a woman's quality of life.

HRT is a medical treatment for the menopause. It provides low doses of the hormone estrogen, with or without progestogen, which a woman no longer produces.

The review notes that the risk-benefit ratio of HRT has always been debated and discusses previous studies examining the effects of HRT.

The Women's Health Initiative Study in 2003 examined the effect of HRT on healthy postmenopausal women with a particular interest in cardiovascular outcomes. The study reported an increase in breast cancer, stroke and venous thromboembolism. Consequently, an 80% reduction in HRT use was reported. However, the re-analysis in 2007 demonstrated that giving HRT to women within 10 years of the menopause was associated with fewer risks and a reduction in cardiovascular problems.

The Million Women Study in 2001 suggested that HRT use increased the risk of breast cancer significantly and the Cochrane Collaboration systematic review identified an increased risk of similar conditions.

However, the authors of the TOG review highlight that such studies failed to address the effect of HRT in symptomatic younger postmenopausal women and have not addressed the benefits of HRT given at the window of opportunity, for example, administrating HRT for symptom relief during the early phase of the menopausal transition.

Additionally, the review advises that any woman with relative contraindications should be offered the option of discussing this further with a menopause specialist. Women with premature ovarian sufficiency should be strongly advised to consider taking HRT until the average menopausal age of 51.4 years, state the authors.

The authors conclude that doctors should not be concerned about discussing the risks and benefits of HRT with women who have menopausal symptoms, or be hesitant to offer a trial of appropriate treatment. They also emphasise that HRT is a patient choice.

Shagaf Bakour, Honorary Senior Lecturer and Consultant Obstetrician and Gynaecologist at City Hospital, Birmingham, and co-author of the review said:

"Women are sometimes concerned about the increased risk of breast cancer related to HRT. However, this risk is much lower than that associated with other factors such as obesity, alcohol consumption and later maternal age.

"HRT is the most effective treatment for symptoms of the menopause and when HRT is individually tailored, women gain maximum advantages and the risks are minimised.

"There are various types and regimens of HRT and healthcare professionals will be able to advise on the suitability of HRT to any woman."

Jason Waugh, TOG Editor-in-chief added: "The use of HRT is an individual decision, which a woman can only make once she has been given correct information and advice from healthcare professionals.

"If women have any concerns about menopausal symptoms or HRT, they should talk to their doctor who will be happy to discuss treatment options further." The Obstetrician & Gynaecologist (TOG) is published quarterly and is the Royal College of Obstetricians and Gynaecologists' (RCOG) medical journal for continuing professional development. TOG is an editorially independent, peer reviewed journal aimed at providing health professionals with updated information about scientific, medical and clinical developments in the specialty of obstetrics and gynaecology.

INFORMATION:

To view further information about the 2013 British Menopause Society & Women's Health Concern recommendations on hormone replacement therapy, please click here. For patient information about the use of HRT to treat symptoms of menopause, please visit Women's Health Concern. For healthcare professionals, please visit the British Menopause Society. Reference S H Bakour, J Williamson. Latest evidence on using hormone replacement therapy in the menopause. The Obstetrician & Gynaecologist 2014; http://onlinelibrary.wiley.com/doi/10.1111/tog.12155/



ELSE PRESS RELEASES FROM THIS DATE:

Less than half of UK prescriptions for antipsychotics issued for main licensed conditions

2014-12-19
Less than half of UK prescriptions for antipsychotic drugs are being issued to treat the serious mental illnesses for which they are mainly licensed, reveals research published in the online journal BMJ Open. Instead, they may often be prescribed 'off label' to older people with other conditions, such as anxiety and dementia, despite the greater risk of potentially serious side effects in this age group, the findings indicate. The researchers analysed family doctors' prescribing patterns for first and second generation antipsychotic drugs across the UK between 2007 ...

Don't be tempted to buy your teen a cheap (old) car, parents warned

2014-12-19
Almost half of teen drivers killed on US roads in the past few years were driving vehicles that were 11 or more years old, and often lacking key safety features, reveals research published online in Injury Prevention. Parents, who are usually the ones stumping up for a car, could be putting their children's lives at risk by focusing on cost, warn the researchers. The prevalence of fatal road traffic collisions among US teens has fallen sharply since 1996. Yet per mile driven, rates of police-reported and fatal crashes involving teens are around three times those for ...

People with blood groups A, B and AB at higher risk of type 2 diabetes than group O

2014-12-19
A study of more than 80,000 women has uncovered different risks of developing type 2 diabetes associated with different blood groups, with the biggest difference a 35% increased risk of type 2 diabetes found in those with group B, Rhesus factor positive (R+) blood compared with the universal donor group O, Rhesus factor negative (R-). The study is published in Diabetologia (the journal of The European Association for the Study of Diabetes) and is by Dr Guy Fagherazzi, and Dr Françoise Clavel-Chapelon, Center for Research in Epidemiology and Population Health, INSERM, ...

The Lancet: Doctor who survived Ebola received experimental drug treatment

2014-12-19
A Ugandan doctor, who contracted Ebola in Sierra Leone, survived after being flown to Germany for aggressive treatment involving a new drug under clinical development for vascular leakage [1]. Dr Timo Wolf and colleagues, from University Hospital Frankfurt in Germany, detail the successful intensive-care treatment the doctor received under biosafety level 4 conditions in an Article published in The Lancet. On 28 September, 2014, the 38-year old doctor, who was in charge of an Ebola virus treatment unit in Lakka, Sierra Leone, developed a fever and diarrhoea. He tested ...

The Lancet: Most commonly prescribed glaucoma drug reduces risk of vision loss by more than 50 percent over 2 years

2014-12-19
Prostaglandin analogue eye drops, the most commonly prescribed treatment for glaucoma, can greatly reduce risk of vision loss in people with open angle glaucoma (OAG), one of the leading causes of blindness, according to the first placebo-controlled trial to assess their vision-preserving effect published in The Lancet. "Medication to lower raised eye pressure has been used for decades as the main treatment for OAG to delay progressive vision loss. But, until now, the extent to which the most frequently prescribed class of pressure-lowering drugs (prostaglandin analogues) ...

Older kidney donors with hypertension may have good kidney health following donation

2014-12-19
Highlight Kidney donors with hypertension had slightly fewer nephrons (the kidney's filtering units) at the time of donation than similarly aged donors with normal blood pressure; however, 6 months following their surgery, hypertensive and non-hypertensive donors both maintained excellent blood pressure control and had similarly robust compensatory kidney responses. Nearly 6,000 people donate a kidney in the United States each year. Washington, DC (December 18, 2014) -- With proper monitoring, kidney donation may be safe for individuals with high blood pressure, according ...

Ability to balance on 1 leg may reflect brain health and stroke risk

2014-12-18
Struggling to balance on one leg for 20 seconds or longer was linked to an increased risk for small blood vessel damage in the brain and reduced cognitive function in otherwise healthy people with no clinical symptoms, according to new research in the American Heart Association's journal Stroke. "Our study found that the ability to balance on one leg is an important test for brain health," said Yasuharu Tabara, Ph.D., lead study author and associate professor at the Center for Genomic Medicine at Kyoto University Graduate School of Medicine in Kyoto, Japan. "Individuals ...

Local enforcement of federal immigration laws affects immigrant Hispanics' healthcare

2014-12-18
WINSTON-SALEM, N.C. - Dec. 18, 2014 - State and local enforcement of federal immigration laws can have an adverse impact on the use of health care services by immigrant Hispanics, according to a North Carolina-based study by Wake Forest Baptist Medical Center researchers. The study, published in the Dec. 18 issue of the American Journal of Public Health, analyzed both birth records and information collected in focus groups and individual interviews. "Our findings suggest that immigration enforcement policies negatively affect the health of immigrant Hispanics, including ...

High socioeconomic status increases discrimination, depression risk in black young adults

2014-12-18
An investigation into factors related to disparities of depression in young adults has found that higher parental education - which has a protective effect for white youth - can also increase the risk of depression for black youth. The MassGeneral Hospital for Children (MGHfC) study published online in the Journal of Pediatrics also found that, among high-socioeconomic-status black youth, greater perceptions of being discriminated against cancelled out the protective effects of parental education. "High socioeconomic status (SES) - particularly higher parent education ...

Research shows E.B. White was right in Charlotte's Web

2014-12-18
Before Charlotte the spider spelled the word "humble" in her web to describe Wilbur the pig, she told Templeton the rat that the word meant "not proud." That's probably what most people say if you put them on the spot. But if you give them time to think about it deeply, like a new study just did, other themes emerge that have a lot to do with learning. And these intellectual dimensions of humility describe the spider as well or better than the pig. "Wilbur has many of the dimensions of humility in general: regard for others, not thinking too highly of himself - but ...

LAST 30 PRESS RELEASES:

These giant, prehistoric salmon had tusk-like teeth

New study infers our wellbeing by analyzing the language we use around ageing, using language markers to enable "a different type of access to individuals’ inner worlds"

New research confirms plastic production is directly linked to plastic pollution

MSU researchers uncover 'parallel universe' in tomato genetics

Grey cuckoo, red cuckoo: unveiling the genomic secrets of color polymorphism in female cuckoo birds

CHOP researchers discover underlying biology behind Fontan-associated liver disease

A flexible microdisplay can monitor brain activity in real-time during brain surgery

Diversity and productivity go branch-in-branch

Color variants in cuckoos: the advantages of rareness

Laser technology offers breakthrough in detecting illegal ivory

Why can’t robots outrun animals?

After spinal cord injury, neurons wreak havoc on metabolism

Network model unifies recency and central tendency biases

Ludwig Lausanne scientists identify and show how to target a key tumor defense against immune attack

Can climate change accelerate transmission of malaria? Pioneering research sheds light on impacts of temperature

A new attempt to identify salt gland development and salt resistance genes of Limonium bicolor ——Identification of bHLH gene family and its function analysis in salt gland development

The SAPIENS Podcast named finalist at the 16th Annual Shorty Awards

Startup financing gender gaps greater in societies where women are more empowered

Postpartum depression after adolescent stress shows a dysregulated HPA axis: a cross-species translational study

When studies conflict: building a decision-support system for clinicians

Artificial sweetener has potential to damage gut

Gene-based therapy restores cellular development and function in brain cells from people with Timothy syndrome

MD Anderson Research Highlights for April 24, 2024

Child pedestrians, self-driving vehicles: What’s the safest scenario for crossing the road?

Mount Sinai researchers the first to apply single-cell analysis to reveal mechanisms of a common complication of Crohn’s disease

Scientists unveil genetics behind development of gliding

Safety of ancestral monovalent COVID-19 vaccines in children

Reversals in the decline of heart failure mortality in the US

Recreational marijuana laws and teen marijuana use, 1993-2021

Manchester scientists found novel one-dimensional superconductor

[Press-News.org] Latest evidence on using hormone replacement therapy for treating menopausal symptoms